Leveraging in vitro & in vivo Preclinical PK/PD Data to Bridge the Translational Gap for ADC & CD3 Bispecific Clinical Development
Time: 9:30 am
day: Day Two
Details:
- Bridging preclinical data to clinical predictions, including the use of non-clinical data for efficacious dose predictions and safety mitigations
- Strategies to empower dose predictions of an ADC and a CD3 bi-specific
- Assessing the different model data to be leveraged and understanding the opportunities and challenges with them
